All In Biotech

Drug Trial Radar · NCT03839862

Faecal Analyses in Spondyloarthritis Therapy

Faecal Analyses in Spondyloarthritis Therapy: A Prospective Observational Study of the Intestinal Microbiome in Patients With Spondyloarthropathy Receiving TNF-inhibition.

Last checked: Nov 20, 2026Latest source record: Mar 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Jan 1, 2019

Primary completion

Dec 31, 2025

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Region SkaneAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 15, 2019

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the intestinal microbiome and disease activity in patients with spondyloarthropathies receiving immunosuppressive therapy. Patients will be analysed at two time points in reference to two predefined primary endpoints: * Changes in intestinal microbiome * Response to therapy The investigators want to evaluate if successful treatment of spondylarthropathy coincide with specific changes in the gut flora.

Conditions

  • Spondyloarthropathies
  • Ankylosing Spondylitis

Interventions

  • TNF-inhibitionDrug

    Initiation of immunosuppression with any TNF-inhibitor, e.g. infliximab, etanercept or adalimumab

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in gut floraTime frame: Change from baseline Dysbiosis Index Score at 6 months
  2. Change in disease activity/treatment response at follow upTime frame: Change from baseline BASDAI at 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Reumatologi SUS Lund, Region Skåne

    Lund, Sweden · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.